CIK 0001217234 · Large accelerated filer
CareDx, Inc.
Sign in to watch- Ticker
- CDNA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943316839
- Phone
- 415-287-2300
- Business address
- 8000 MARINA BLVD, 4TH FLOOR, BRISBANE, CA, 94005
- Former names
- XDx, Inc., EXPRESSION DIAGNOSTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,154,003
- in 2 filings, $5.2M under 10b5-1 plans
Net −$5,154,003. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-26 | Maag Peter Director | Option exercise 10b5-1 | +5,000 | $12.24 | $61K | 335,024 |
| 2024-11-26 | Maag Peter Director | Sale 10b5-1 | −5,000 | $25.00 | $125K | 330,024 |
| 2024-11-26 | Maag Peter Director | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 1,250 | ||
| 2024-11-25 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −365 | $24.00 | $9K | 113,012 |
| 2024-11-25 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −858 | $24.00 | $21K | 112,154 |
| 2024-11-18 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −3,656 | $21.65 | $79K | 115,255 |
| 2024-11-18 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −807 | $22.00 | $18K | 114,448 |
| 2024-11-18 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −1,071 | $22.00 | $24K | 113,377 |
| 2024-11-06 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −452 | $23.21 | $10K | 118,911 |
| 2024-11-01 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −1,905 | $22.64 | $43K | 119,363 |
| 2024-11-01 | Jain Abhishek Chief Financial Officer | Shares withheld for taxes | −7,371 | $22.64 | $167K | 265,536 |
| 2024-11-01 | Bickerstaff George Director | Option exercise | +5,255 | $5.85 | $31K | 120,801 |
| 2024-11-01 | Bickerstaff George Director | Option exercise | +2,226 | $5.49 | $12K | 123,027 |
| 2024-11-01 | Bickerstaff George Director | Option exercise · Stock Option (right to buy) | −5,255 | 0 | ||
| 2024-11-01 | Bickerstaff George Director | Option exercise · Stock Option (right to buy) | −2,226 | 0 | ||
| 2024-10-04 | Goldberg Michael Director | Grant or award | +837 | 139,072 | ||
| 2024-09-12 | Meng Jessica Chief Commercial Officer | Grant or award | +52,576 | 52,576 | ||
| 2024-09-12 | Meng Jessica Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +75,488 | 75,488 | ||
| 2024-09-12 | Kennedy Keith Chief Operating Officer | Grant or award | +70,101 | 70,101 | ||
| 2024-09-12 | Kennedy Keith Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +100,651 | 100,651 |
Page 10 of 17 · 324 trades